Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Research Report 2023

Report ID: 1991152 | Published Date: Sep 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antacids
        1.2.3 Pro-kinetic agents
        1.2.4 H2 Receptor Blockers
        1.2.5 Proton Pump Inhibitors (PPIs)
    1.3 Market by Application
        1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Heartburn
        1.3.3 Acid reflux disorders
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2017-2028)
    2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Region
        2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Dynamics
        2.3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Trends
        2.3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
        2.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
        2.3.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue
        3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
    3.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
        3.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2021
    3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
    3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Type
    4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application
    5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
    6.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
    6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
    7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
    9.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
        11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
        11.1.5 AstraZeneca Recent Development
    11.2 Eisai
        11.2.1 Eisai Company Detail
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
        11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
        11.2.5 Eisai Recent Development
    11.3 GSK
        11.3.1 GSK Company Detail
        11.3.2 GSK Business Overview
        11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
        11.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
        11.3.5 GSK Recent Development
    11.4 Takeda
        11.4.1 Takeda Company Detail
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
        11.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
        11.4.5 Takeda Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
        11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antacids
    Table 3. Key Players of Pro-kinetic agents
    Table 4. Key Players of H2 Receptor Blockers
    Table 5. Key Players of Proton Pump Inhibitors (PPIs)
    Table 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2023-2028)
    Table 12. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
    Table 13. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
    Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
    Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
    Table 16. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2021)
    Table 19. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
    Table 23. Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. AstraZeneca Company Detail
    Table 44. AstraZeneca Business Overview
    Table 45. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 46. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. AstraZeneca Recent Development
    Table 48. Eisai Company Detail
    Table 49. Eisai Business Overview
    Table 50. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 51. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Eisai Recent Development
    Table 53. GSK Company Detail
    Table 54. GSK Business Overview
    Table 55. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 56. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. GSK Recent Development
    Table 58. Takeda Company Detail
    Table 59. Takeda Business Overview
    Table 60. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 61. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. Takeda Recent Development
    Table 63. Johnson & Johnson Company Detail
    Table 64. Johnson & Johnson Business Overview
    Table 65. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 66. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Johnson & Johnson Recent Development
    Table 68. Research Programs/Design for This Report
    Table 69. Key Data Information from Secondary Sources
    Table 70. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Antacids Features
    Figure 3. Pro-kinetic agents Features
    Figure 4. H2 Receptor Blockers Features
    Figure 5. Proton Pump Inhibitors (PPIs) Features
    Figure 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Heartburn Case Studies
    Figure 8. Acid reflux disorders Case Studies
    Figure 9. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
    Figure 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2021
    Figure 16. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
    Figure 45. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
    Figure 46. GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
    Figure 47. Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
Frequently Asked Questions
Gastroesophageal Reflux Disease (GERD) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastroesophageal Reflux Disease (GERD) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastroesophageal Reflux Disease (GERD) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Genitourinary Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More